Erythromycin Cyclic 11,12 Carbonate A | CAS 55224-05-0 - Solicitar cotización

Erythromycin Cyclic 11,12 Carbonate A is chemically (3aR,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-11-hydroxy-8-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3a,7,9,11,13,15-hexamethyldecahydro-6H-[1,3]dioxolo[4,5-c][1]oxacyclotetradecine-2,6,14(7H)-trione. It is also known as Erythromycin Cyclocarbonate ; Davercin. Erythromycin Cyclic 11,12 Carbonate A is supplied with detailed characterization data compliant with regulatory guideline. Erythromycin Cyclic 11,12 Carbonate A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erythromycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.